Canada - English - Health Canada

pro doc limitee - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Canada - English - Health Canada

sanis health inc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; hypromellose - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; maltodextrin; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - gliclazide - oral tablet - 80mg

Canada - English - Health Canada

sanis health inc - gliclazide - tablet (extended-release) - 30mg - gliclazide 30mg

Canada - English - Health Canada

sanis health inc - gliclazide - tablet (extended-release) - 60mg - gliclazide 60mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 80 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - indicated for the treatment of diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flamingo pharma (uk) ltd - gliclazide - oral tablet - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - gliclazide - oral tablet - 80mg